# CDER/OC

Source: https://www.globalkeysolutions.net/offices/cderoc/cdc5dc9f-903e-429f-a2a9-d3c523f622dd

---

## Details

- Created At: 2026-01-06T17:23:32.406424+00:00

## Records at this office

- [Zhejiang Huahai Pharmaceutical](https://www.globalkeysolutions.net/records/eir/zhejiang-huahai-pharmaceutical/4f117789-6333-46f2-825b-833001cf712d/) — date: May 19, 2017
- [Taiho Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/records/eir/taiho-pharmaceutical-co-ltd/d64f85d0-3cc5-496a-978c-41118ae87f0c/) — date: May 22, 2015

## Related Offices

- [Department of Health and Human Services, Food and Drug Administration](https://www.globalkeysolutions.net/offices/department-of-health-and-human-services-food-and-drug-administration/1c42524a-5012-48a5-b3c5-f81450677146)
- [Center of Drug Evaluation and Research](https://www.globalkeysolutions.net/offices/center-of-drug-evaluation-and-research/76775cb1-60be-4129-aa2f-0b86a93b8fde)
- [Test Office](https://www.globalkeysolutions.net/offices/test-office/538726d7-de2b-4202-8f89-8a73b6366173)
- [Office of Specialty Medicine](https://www.globalkeysolutions.net/offices/office-of-specialty-medicine/d33e4b6a-7112-4b3e-8667-1453d3ddae47)
- [Office of Oncologic Diseases Office of New Drugs](https://www.globalkeysolutions.net/offices/office-of-oncologic-diseases-office-of-new-drugs/44611783-d91c-4be8-849c-ee8666e43c4d)